Astex Pharmaceuticals
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1999 |
| Headquarters | European Corporate and Research headquarters in Cambridge, UK (Astex Therapeutics Limited) |
Key people | Harren Jhoti (President and CEO) David Rees (Chief Scientific Officer) |
| Products | Therapeutics for oncology and CNS disorders |
| Parent | Otsuka Pharmaceutical |
| Website | astx |
Astex Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs in oncology and diseases of the central nervous system. Astex was founded in 1999 by Sir Tom Blundell, Chris Abell & Harren Jhoti, and is located in Cambridge, England.
Astex is part of the Otsuka group of companies and is a wholly-owned subsidiary of Otsuka Pharmaceutical Co. Ltd, headquartered in Tokyo, Japan.